Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen-Rich Water and Liver Disease in Rats

The Preventive Role of Hydrogen-Rich Water in Thioacetamide-Induced Cholangiofibrosis in Rat Assessed by Automated Histological Classification

Research hubs: Digestive System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for The Preventive Role of Hydrogen-Rich Water in Thioacetamide-Induced Cholangiofibrosis in Rat Assessed by Automated Histological Classification
Evidence type
Animal study (rat)
Authors
Chaofu Li, Xing Zhao, Xiaoqiang Gu, Ying Chen, Guanzhen Yu
Journal
Frontiers in Pharmacology
Year
2021
Study Type
Rat
Delivery
Water (Electrolysis)
Dose
H2-rich water administered throughout the study period
Duration
3 months
Outcome
Positive
Peer Reviewed
Yes
Cited by
12 (OpenAlex, as of November 2026)
Country
China

TL;DR

Drinking hydrogen-rich water can help prevent liver damage and a condition that can lead to liver cancer, while also improving overall quality of life.

Key Finding

In rats with chemically-induced liver damage, hydrogen-rich water reduced the incidence of cholangiofibrosis lesions from 100% to 57% and reduced tumor development from 100% to 12.5%.

Summary

Researchers gave rats a chemical that damages the liver and causes a condition called cholangiofibrosis (scarring of bile ducts that can lead to cancer). Some rats also received hydrogen-rich water throughout the study. Rats drinking hydrogen-rich water had fewer liver lesions and less tumor development compared to rats that didn't receive it, and the hydrogen water appeared safe and improved their quality of life.

Practical Takeaway

This is an animal study showing hydrogen-rich water may help prevent liver scarring and tumor formation in rats exposed to liver toxins. However, these results cannot be directly applied to humans yet—further research in human subjects would be needed to determine if similar benefits occur in people. The study suggests a potential mechanism involving changes to gut bacteria and metabolism, but this remains preliminary evidence.

Abstract (excerpt)

Background: Cholangiofibrosis is a controversial intrahepatic cholangial lesion that precedes the development of cholangiocarcinoma. Here, we demonstrate that molecular hydrogen (H2) can be used to effectively prevent cholangiofibrosis.Methods: The safety and quality of life (QOL) of rats was…

Read the full abstract on PubMed